PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Surgical, Medical, Dental and Morphological Sciences, University of Modena and Reggio Emilia, Modena, Italy.\', \'Unit of Statistical and Methodological Support to Clinical Research, Azienda Ospedaliero-Universitaria, Modena, Italy.\', \'Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, Modena, Italy.\', \'Infectious Disease Clinic, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.\', \'Department of Anesthesia and Intensive Care, University of Modena and Reggio Emilia, Modena, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1371/journal.pone.0251378
?:doi
?:hasPublicationType
?:journal
  • PloS one
is ?:pmid of
?:pmid
?:pmid
  • 34383784
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.164
?:rankingScore_hIndex
  • 241
is ?:relation_isRelatedTo_publication of
?:title
  • The impact of tocilizumab on respiratory support states transition and clinical outcomes in COVID-19 patients. A Markov model multi-state study.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all